CBAY Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 7.00%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $7,806,823.97

CymaBay Therapeutics Insider Trading History Chart

CymaBay Therapeutics Share Price & Price History

^$32.48

+0.30 (1.20%)

As of 04/1/2024 01:00 AM ET

Days: 30 | 90 | 365

New crypto project uncovers 2,050% in 65 days

From InvestorPlace | Ad

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

CymaBay Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/12/2024	Janet Dorling	Director	Sell	6,000	$31.97	$191,820.00
1/19/2024	Charles McWherter	Insider	Sell	18,403	$23.67	$435,599.01	15,000
1/16/2024	Daniel Menold	VP	Sell	10,000	$23.58	$235,800.00
1/16/2024	Paul T. Quinlan	General Counsel	Sell	5,000	$23.58	$117,900.00
1/10/2024	Janet Dorling	Director	Sell	6,000	$23.86	$143,160.00
12/18/2023	Charles McWherter	Insider	Sell	11,332	$21.48	$243,411.36	15,000
12/15/2023	Daniel Menold	VP	Sell	21,497	$21.99	$472,719.03
12/15/2023	Paul T. Quinlan	General Counsel	Sell	5,000	$21.98	$109,900.00
12/11/2023	Janet Dorling	Director	Sell	6,000	$20.07	$120,420.00
12/11/2023	Sujal Shah	CEO	Sell	64,865	$20.00	$1,297,300.00	171,301
11/17/2023	Charles McWherter	Insider	Sell	11,342	$18.28	$207,331.76	15,000
11/15/2023	Paul T. Quinlan	General Counsel	Sell	5,000	$17.38	$86,900.00
10/18/2023	Charles McWherter	Insider	Sell	21,743	$14.07	$305,924.01	15,000
10/16/2023	Paul T. Quinlan	General Counsel	Sell	5,000	$13.76	$68,800.00
10/9/2023	Sujal Shah	CEO	Sell	64,861	$14.20	$921,026.20	171,301
9/29/2023	Kurt von Emster	Director	Sell	15,921	$15.68	$249,641.28	90,000
9/18/2023	Charles McWherter	Insider	Sell	21,746	$16.22	$352,720.12	15,000
9/15/2023	Paul T. Quinlan	General Counsel	Sell	53,000	$16.87	$894,110.00
8/18/2023	Charles McWherter	Insider	Sell	21,746	$11.47	$249,426.62	15,000
8/15/2023	Paul T. Quinlan	General Counsel	Sell	5,000	$11.91	$59,550.00
8/9/2023	Daniel Menold	VP	Sell	20,945	$12.35	$258,670.75
7/18/2023	Charles McWherter	Insider	Sell	21,749	$11.43	$248,591.07	15,000
7/14/2023	Paul T. Quinlan	General Counsel	Sell	5,000	$11.81	$59,050.00
6/30/2023	Paul T. Quinlan	General Counsel	Sell	5,000	$10.05	$50,250.00
6/20/2023	Charles McWherter	Insider	Sell	21,749	$8.16	$177,471.84	15,000
5/18/2023	Charles McWherter	Insider	Sell	21,749	$9.08	$197,480.92	15,000
5/15/2023	Paul T. Quinlan	General Counsel	Sell	5,000	$10.37	$51,850.00
4/17/2023	Dennis D. Kim	Insider	Sell	112,219	$9.54	$1,070,569.26	20,000
4/13/2023	Dennis D. Kim	Insider	Sell	7,781	$8.98	$69,873.38	20,000
3/28/2023	Dennis D. Kim	Insider	Sell	100	$8.98	$898.00	20,000
6/6/2022	Sujal Shah	CEO	Buy	51,301	$1.95	$100,036.95	171,301
1/19/2022	Dennis D. Kim	Insider	Buy	20,000	$3.04	$60,800.00

New crypto project uncovers 2,050% in 65 days

From InvestorPlace | Ad

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

SEC Filings (Institutional Ownership Changes) for CymaBay Therapeutics (NASDAQ:CBAY)

95.03% of CymaBay Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

CymaBay Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/22/2024	PNC Financial Services Group Inc.	8,179	$0.19M	0.0%	+1,833.6%	0.007%
3/11/2024	Vanguard Group Inc.	6,306,149	$148.95M	0.0%	+9.7%	5.497%
3/5/2024	Wellington Management Group LLP	202,782	$4.79M	0.0%	N/A	0.177%
3/4/2024	Tucker Asset Management LLC	3,749	$89K	0.0%	N/A	0.003%
3/1/2024	Goldman Sachs Group Inc.	630,735	$14.90M	0.0%	+12.5%	0.556%
2/28/2024	American International Group Inc.	56,268	$1.33M	0.0%	+14.9%	0.050%
2/26/2024	Perceptive Advisors LLC	4,024,400	$95.06M	2.1%	-0.5%	3.549%
2/20/2024	Quarry LP	4,000	$94K	0.0%	-55.6%	0.004%
2/16/2024	Price T Rowe Associates Inc. MD	4,465,161	$105.47M	0.0%	+134.6%	3.938%
2/15/2024	Chartwell Investment Partners LLC	49,388	$1.17M	0.0%	+0.7%	0.044%
2/15/2024	Virtus ETF Advisers LLC	4,278	$0.10M	0.1%	-62.3%	0.004%
2/15/2024	Legal & General Group Plc	86,244	$2.04M	0.0%	+3.7%	0.076%
2/15/2024	Vanguard Group Inc.	6,306,149	$148.95M	0.0%	+9.7%	5.561%
2/15/2024	Voya Investment Management LLC	122,998	$2.91M	0.0%	+209.8%	0.108%
2/15/2024	Novo Holdings A S	900,000	$21.26M	1.4%	-42.5%	0.794%
2/15/2024	Nuveen Asset Management LLC	751,508	$17.75M	0.0%	+7.5%	0.663%
2/15/2024	Octagon Capital Advisors LP	2,673,750	$63.15M	10.1%	-11.3%	2.358%
2/15/2024	Price T Rowe Associates Inc. MD	4,465,161	$105.47M	0.0%	+134.6%	3.938%
2/15/2024	Profund Advisors LLC	26,263	$0.62M	0.0%	+38.5%	0.023%
2/15/2024	Parkwood LLC	11,191	$0.26M	0.0%	N/A	0.010%
2/15/2024	Gotham Asset Management LLC	19,081	$0.45M	0.0%	-52.8%	0.017%
2/15/2024	Healthcare of Ontario Pension Plan Trust Fund	45,000	$1.06M	0.0%	N/A	0.040%
2/15/2024	Clear Street Markets LLC	8,405	$0.20M	0.0%	N/A	0.007%
2/15/2024	Comerica Bank	69,260	$1.64M	0.0%	+5,019.0%	0.061%
2/14/2024	Royal Bank of Canada	94,260	$2.23M	0.0%	+31.9%	0.083%
2/14/2024	Point72 Asset Management L.P.	2,573,700	$60.79M	0.1%	+5.9%	2.270%
2/14/2024	Avoro Capital Advisors LLC	11,111,111	$262.44M	3.6%	+7.9%	9.798%
2/14/2024	Verition Fund Management LLC	10,170	$0.24M	0.0%	-4.9%	0.009%
2/14/2024	Sei Investments Co.	70,972	$1.68M	0.0%	-15.9%	0.063%
2/14/2024	Vestal Point Capital LP	1,625,000	$38.38M	4.1%	N/A	1.433%
2/13/2024	PEAK6 Investments LLC	10,006	$0.24M	0.0%	N/A	0.009%
2/13/2024	Envestnet Asset Management Inc.	39,544	$0.93M	0.0%	-37.7%	0.035%
2/13/2024	Northern Trust Corp	1,090,087	$25.75M	0.0%	+8.2%	0.961%
2/13/2024	American International Group Inc.	56,268	$1.33M	0.0%	+14.9%	0.050%
2/13/2024	Tower Research Capital LLC TRC	10,517	$0.25M	0.0%	+459.1%	0.009%
2/13/2024	Affinity Asset Advisors LLC	1,090,441	$25.76M	4.8%	-3.4%	0.962%
2/13/2024	Goldman Sachs Group Inc.	630,735	$14.90M	0.0%	+12.5%	0.556%
2/13/2024	Rafferty Asset Management LLC	18,428	$0.44M	0.0%	+76.8%	0.016%
2/13/2024	NEOS Investment Management LLC	15,189	$0.36M	0.0%	N/A	0.013%
2/13/2024	The Manufacturers Life Insurance Company	129,280	$3.05M	0.0%	+30.0%	0.114%
2/13/2024	Campbell & CO Investment Adviser LLC	21,714	$0.51M	0.0%	-39.9%	0.019%
2/13/2024	California State Teachers Retirement System	88,882	$2.10M	0.0%	-6.1%	0.078%
2/12/2024	TD Asset Management Inc	157,556	$3.72M	0.0%	+71.3%	0.139%
2/12/2024	Steward Partners Investment Advisory LLC	17,600	$0.42M	0.0%	+14.7%	0.016%
2/9/2024	Westfield Capital Management Co. LP	700,056	$16.54M	0.1%	N/A	0.617%
2/9/2024	Orion Portfolio Solutions LLC	12,357	$0.29M	0.0%	-19.4%	0.011%
2/9/2024	US Bancorp DE	28,986	$0.69M	0.0%	-35.7%	0.026%
2/9/2024	Cambridge Investment Research Advisors Inc.	10,533	$0.25M	0.0%	N/A	0.009%
2/9/2024	Franklin Resources Inc.	3,267,927	$77.19M	0.0%	-1.2%	2.882%
2/9/2024	PNC Financial Services Group Inc.	8,179	$0.19M	0.0%	+1,833.6%	0.007%
2/8/2024	Nicholas Investment Partners LP	434,507	$10.26M	1.2%	-76.4%	0.383%
2/8/2024	First Turn Management LLC	1,497,331	$35.37M	5.1%	N/A	1.320%
2/8/2024	Moran Wealth Management LLC	22,246	$0.53M	0.0%	N/A	0.020%
2/7/2024	Principal Financial Group Inc.	13,068	$0.31M	0.0%	+26.3%	0.012%
2/7/2024	Cary Street Partners Investment Advisory LLC	13,900	$0.33M	0.0%	-30.5%	0.012%
2/7/2024	BNP Paribas Financial Markets	169,082	$3.99M	0.0%	+162.9%	0.149%
2/7/2024	Teacher Retirement System of Texas	18,430	$0.44M	0.0%	-20.3%	0.016%
2/6/2024	Charles Schwab Investment Management Inc.	853,475	$20.16M	0.0%	+6.9%	0.753%
2/6/2024	AJOVista LLC	1,794	$42K	0.1%	N/A	0.002%
2/6/2024	Amalgamated Bank	16,279	$0.39M	0.0%	+9.5%	0.014%
2/6/2024	Swiss National Bank	155,400	$3.67M	0.0%	-14.4%	0.137%
2/5/2024	Victory Capital Management Inc.	689,603	$16.29M	0.0%	-33.5%	0.608%
2/5/2024	Russell Investments Group Ltd.	111,550	$2.64M	0.0%	+2,621.4%	0.098%
2/2/2024	Golden State Equity Partners	54,289	$1.28M	0.3%	+8.6%	0.048%
2/2/2024	Harvest Fund Management Co. Ltd	1,076	$26K	0.0%	N/A	0.001%
2/1/2024	New York State Common Retirement Fund	95,043	$2.25M	0.0%	+47.6%	0.084%
2/1/2024	Jennison Associates LLC	3,992,711	$94.31M	0.1%	+12.3%	3.521%
1/31/2024	Wetzel Investment Advisors Inc.	3,000	$71K	0.0%	N/A	0.003%
1/31/2024	Calamos Advisors LLC	56,825	$1.34M	0.0%	N/A	0.050%
1/29/2024	Clarius Group LLC	8,938	$0.21M	0.0%	N/A	0.008%
1/26/2024	Moody Aldrich Partners LLC	261,415	$6.18M	1.1%	-19.8%	0.231%
1/25/2024	Allspring Global Investments Holdings LLC	80,029	$1.89M	0.0%	N/A	0.071%
1/25/2024	International Assets Investment Management LLC	133,311	$3.15M	0.0%	N/A	0.118%
1/25/2024	Strategic Blueprint LLC	15,800	$0.37M	0.0%	-6.0%	0.014%
1/25/2024	Nisa Investment Advisors LLC	1,211	$29K	0.0%	-42.1%	0.001%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	48,669	$1.15M	0.0%	+1.1%	0.043%
1/24/2024	International Assets Investment Management LLC	133,311	$3.15M	0.0%	N/A	0.118%
1/24/2024	China Universal Asset Management Co. Ltd.	13,114	$0.31M	0.1%	+421.2%	0.012%
1/17/2024	Assenagon Asset Management S.A.	746,353	$17.63M	0.0%	N/A	0.658%
1/16/2024	Raymond James Financial Services Advisors Inc.	113,883	$2.69M	0.0%	+12.4%	0.100%
1/16/2024	Raymond James & Associates	57,286	$1.35M	0.0%	+45.0%	0.051%
1/16/2024	Legato Capital Management LLC	40,393	$0.95M	0.1%	+96.8%	0.036%
1/12/2024	SG Americas Securities LLC	4,780	$0.11M	0.0%	-69.1%	0.004%
12/18/2023	Vanguard Group Inc.	5,747,587	$85.70M	0.0%	+11.6%	5.068%
12/7/2023	Hudson Bay Capital Management LP	30,000	$0.45M	0.0%	N/A	0.026%
12/6/2023	Citigroup Inc.	18,414	$0.28M	0.0%	-62.1%	0.016%
11/24/2023	Deutsche Bank AG	456,106	$6.80M	0.0%	-44.8%	0.402%
11/21/2023	Walleye Capital LLC	47,796	$0.71M	0.0%	-79.6%	0.042%
11/16/2023	Tudor Investment Corp Et Al	24,769	$0.37M	0.0%	N/A	0.022%
11/15/2023	The Manufacturers Life Insurance Company	99,436	$1.48M	0.0%	+164.2%	0.088%
11/15/2023	RA Capital Management L.P.	6,940,000	$103.48M	2.0%	N/A	6.120%
11/15/2023	Baker Avenue Asset Management LP	32,800	$0.49M	0.0%	-37.9%	0.029%
11/15/2023	Royal Bank of Canada	71,449	$1.07M	0.0%	+1,073.6%	0.063%
11/15/2023	Sei Investments Co.	84,420	$1.26M	0.0%	+51.1%	0.074%
11/15/2023	Seven Eight Capital LP	41,556	$0.62M	0.1%	N/A	0.037%
11/15/2023	Legal & General Group Plc	83,189	$1.24M	0.0%	+8.1%	0.073%
11/15/2023	Acuta Capital Partners LLC	418,000	$6.23M	4.2%	-2.8%	0.369%
11/15/2023	Adage Capital Partners GP L.L.C.	4,125,000	$61.50M	0.1%	-6.3%	3.638%
11/15/2023	Alps Advisors Inc.	72,461	$1.08M	0.0%	+1.1%	0.064%
11/15/2023	Affinity Asset Advisors LLC	1,129,376	$16.84M	4.7%	+7.5%	0.996%

Data available starting January 2016

CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta for the treatments of primary biliary cholangitis (PBC). The company also develops MBX-2982, a G protein-coupled receptor 119 (GPR119) agonist, in subjects with type 1 diabetes. It has a license agreement with ABW Cyclops SPV LP to support development of seladelpar for the treatment of PBC. The company was formerly known as Metabolex, Inc. CymaBay Therapeutics, Inc. was incorporated in 1988 and is headquartered in Fremont, California.

Today's Range

Now: $32.48

$32.48

50 Day Range

MA: $32.09

$24.96

$32.48

52 Week Range

Now: $32.48

$7.26

$32.50

Volume

73 shs

Average Volume

4,113,430 shs

Market Capitalization

$3.73 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.32

Who are the company insiders with the largest holdings of CymaBay Therapeutics?: CymaBay Therapeutics' top insider shareholders include:
Sujal Shah (CEO)
Kurt Von Emster (Director)
Dennis D Kim (Insider)
Charles Mcwherter (Insider)
Daniel Menold (VP)
Janet Dorling (Director)
Paul T Quinlan (General Counsel)
Learn More about top insider investors at CymaBay Therapeutics.